HIMSS Global Health Conference & Exhibition 2026: How AI, Interoperability, and Resilience Are Redefining Healthcare Delivery

April, 2026

Held at the Venetian Convention & Expo Center in Las Vegas from March 9–12, HIMSS Global Health Conference & Exhibition 2026 (HIMSS26) brought into sharp focus the intensifying realities of workforce and cost pressures, alongside escalating data and cyber complexity shaping modern healthcare systems. In recent years, providers worldwide have been reeling under sustained strain from workforce shortages, rising operational and labor costs, persistent cyber threats, and increasingly complex regulatory environments, all compounded by the exponential growth of multimodal data. Aging populations, a growing burden of chronic diseases, and lingering post-pandemic fragmentation now characterize operational volatility as a structural condition rather than a temporary disruption. As a result, healthcare organizations are experiencing cascading impacts that extend beyond frontline care delivery into financial performance and patient trust. Large health systems, in particular, are tackling disruptions that originate within clinical silos but rapidly propagate across the enterprise, often culminating in systemic compliance breakdowns. And this exposes the inherent fragility of legacy operating models designed for stable, predictable demand rather than continuous adaptation.

These converging pressures are driving a fundamental reconfiguration of healthcare technology and operational strategy, as underscored during HIMSS26. Rather than continuing to layer isolated point solutions onto already fragmented infrastructures, industry leaders are advancing toward integrated, intelligent ecosystems that embed AI at the core of decision-making, enable seamless and interoperable data flows, and incorporate resilience as a foundational design principle. The conference, which convened over 40,000 stakeholders spanning providers, payors, technology innovators, policymakers, and investors, reflected a decisive shift in industry priorities—from incremental digitization to systemic transformation. HIMSS has evolved beyond its traditional role as a technology showcase to become a barometer of healthcare’s strategic direction, highlighting the urgent need to operationalize AI as a core capability, achieve true data liquidity across systems, and build robust, adaptive infrastructures that can sustain performance amid ongoing uncertainty and disruption.

While HIMSS has long championed digital health, its 2026 edition stood out for aligning announcements, keynotes, and demos with real-world imperatives. Discussions and product unveils emphasized that healthcare providers are rapidly moving from AI experimentation to scaled, accountable deployment. This shift reflects a maturation where technology does not just digitize processes but orchestrates outcomes amid persistent disruption. For instance, companies such as Epic Systems, Artera, and Meditech are demonstrating how AI is being integrated into scalable and accountable healthcare deployments. Epic’s enterprise “Agent Factory” facilitates orchestrated workflows; Artera’s production-grade agentic AI enhances patient access and engagement; and Meditech’s conversational AI incorporates real-time decision-making and actions directly within clinical workflows. Driving this evolution, four pivotal themes were highlighted during the conference.

From Digital Tools to AI-Augmented Clinical Ecosystems

The most prominent theme at HIMSS26 was the maturation of AI from hype-driven pilots to embedded, human-augmented intelligence across clinical and operational workflows. Sessions and preconference forums such as the “AI in Healthcare Forum” stressed embedding AI into the “DNA of healthcare,” focusing on access, transparency, and accountability to deliver measurable impact beyond the “trough of disillusionment.” Avasant’s Healthcare Provider Digital Services 2025 Market Insights report reinforces this trajectory, signaling that accelerated investment in AI-enabled care, interoperability, and patient-centric platforms is no longer optional but foundational to competitiveness across healthcare organizations.

HIMSS26 research highlighted AI’s role in empowering clinicians to make better decisions, with adoption surging toward scalable models in diagnostics, predictive analytics, and workflow optimization. Exhibitors showcased practical integrations, such as Advantech’s medical edge computing for real-time AI at the bedside and Wolters Kluwer’s evidence-based generative AI fusing validated medical knowledge with clinical tools. Keynotes, including those on Day 2, dissected AI’s potential to combat clinician burnout by automating data synthesis and pattern detection, freeing professionals for high-judgment tasks such as ethical decision-making and patient empathy.

Netsmart’s booth emphasized Qualified Health Information Network (QHIN) designation and AI innovations for post-acute care, demonstrating how federated data networks enable privacy-preserving real-world evidence analysis. Fujifilm unveiled AI-integrated enterprise imaging, while PointClickCare launched features delivering clinical intelligence within 24 hours of hospital discharge. Mphasis and HCLTech framed their strategies around AI-driven modernization for payors and providers, enabling real-time insights, predictive risk models, and value-based care transitions.

This evolution underscores that digital maturity is no longer defined by the number of tools deployed, but by how effectively AI supports real-time decision-making and amplifies human expertise in complex, exception-heavy care scenarios such as emergency triage and chronic disease management.

Interoperability as the Foundation for Data-Driven Care

Central to HIMSS26 was the imperative of interoperability, positioned as a nonnegotiable for unlocking AI’s promise. Long plagued by silos, faxes, and proprietary formats, healthcare data exchange is finally yielding to standards such as the Fast Healthcare Interoperability Resources (FHIR) and the Trusted Exchange Framework and Common Agreement (TEFCA), fueled by grassroots pressure and the data-hungry nature of AI.​

Panels underscored that AI thrives only on high-quality, liquid data. Mayo Clinic’s chief clinical informatics officer noted the need to audit data sources for agentic AI, which autonomously pulls and acts on information across systems. Wolters Kluwer’s CEO highlighted how US data abundance, once overwhelming, now powers diagnostics via interoperable flows. Themes included strengthening frameworks for coordinated care, with exhibitors such as RingCentral debuting voice-first AI agents for omnichannel contact centers and Ergotron expanding its fleet management offering for connected devices.

The conference reinforced the importance of data fusion—blending EHRs, IoT from wearables, social determinants, and external signals such as social risk factors—to enhance predictive care models. For Native American and indigenous communities, sessions stressed data sovereignty to ensure culturally attuned interoperability without exploitation. This backbone enables longitudinal insights, reducing readmissions and aligning operations with outcomes in value-based paradigms.

Extending AI Intelligence to Governance, Finance, and Equity

HIMSS26 extended AI’s reach beyond clinics into governance, revenue cycles, and health equity. Vendors addressed the challenge of financial information leakage via AI-powered revenue integrity. For instance, PointClickCare and others are automating discharge insights for faster reimbursements, while Ochsner Health has partnered with CLEAR to enable secure digital patient access, blending biometrics with AI for fraud reduction.​

Cybersecurity emerged as intertwined with AI resilience. According to Sophos’ 2025 global ransomware report, around 50% of organizations paid ransomware demands to recover their data, while only 54% were able to restore data from backups, and 49% of victims fully recovered all their data after paying, highlighting that payment remains common but does not guarantee full recovery. This highlights a critical gap between perceived preparedness and actual resilience, prompting calls for AI-embedded defenses such as predictive threat hunting. Parallel discussions on rural health and clinician burnout emphasized the role of agentic AI in operational workflows, including dynamic staffing optimization and real-time supply chain adjustments to sustain care delivery under constrained conditions.

Equity discussions emphasized AI’s impact in underserved areas, the importance of indigenous data sovereignty, and global efforts toward universal access (for instance, HIMSS European themes).

Risk, Cybersecurity, and Resilience in a Hyper-Connected Era

As healthcare digitizes, HIMSS26 elevated risk management from a compliance checkbox to a strategic core. Cyber exposures, ransomware surges, and regulatory shifts (such as AI governance) amplify stakes, with interconnected systems propagating failures faster.

Demos featured overhaul-like predictive intelligence tailored to health, including AI that fuses sensor data, network telemetry, and threat intel for proactive interventions. Cybersecurity preconferences stressed resilient architectures for distributed care models. Insurance and underwriting panels mirrored supply chain trends, pushing risk ownership into design—partner vetting, zero-trust models, and AI scenario simulations.​

During volatile periods, such as supply disruptions for meds/devices, resilience defines leaders and their ability to embed cyber hygiene, backup orchestration, and adaptive planning yields measurable ROI in uptime and trust.​

Human-Centric AI in Complex Care Environments

Echoing this maturation, HIMSS26 emphasized that trust is becoming the primary constraint on AI adoption in clinical environments, reinforcing a model of human–AI symbiosis rather than full automation. While AI processes vast volumes of data to surface otherwise invisible patterns, clinicians remain central in providing ethical judgment, contextual interpretation, and accountability, especially in high-stakes scenarios such as oncology or pandemics. Conversational AI and decision-support tools further accelerate scenario analysis while preserving human oversight and decision integrity. This balance was a defining theme at HIMSS26, where CEO Hal Wolf’s keynote framed thriving amid change as a function of human-AI collaboration—a thread carried through preconferences focused on clinical insight strategies.

What HIMSS26 Signals for Healthcare Leaders

HIMSS26 offered a unified vision: AI-augmented, interoperable, resilient ecosystems converging tech, data, equity, and humanity. The event and aligned research highlighted how:

  • AI creates baselines across workflows, governance, and equity
  • Interoperability differentiates via data liquidity
  • Resilience shapes investments in cyber, infra, and adaptive operations

The event was not a mere innovation parade but an industry recalibration. As disruptions normalize, advantage accrues to systems sensing risks early, deciding intelligently, and adapting fluidly—prerequisites for sustainable, patient-centered care.

HIMSS26 underscored that healthcare leaders who fail to operationalize AI, interoperability, and resilience within the next 12–24 months risk structural disadvantage, not just incremental lag, as these capabilities rapidly become foundational to the industry’s next era.


By Eratha Poongkuntran, Associate Director and Parnika Gupta, Research Analyst, Avasant

CONTACT US

DISCLAIMER:

Avasant’s research and other publications are based on information from the best available sources and Avasant’s independent assessment and analysis at the time of publication. Avasant takes no responsibility and assumes no liability for any error/omission or the accuracy of information contained in its research publications. Avasant does not endorse any provider, product or service described in its RadarView™ publications or any other research publications that it makes available to its users, and does not advise users to select only those providers recognized in these publications. Avasant disclaims all warranties, expressed or implied, including any warranties of merchantability or fitness for a particular purpose. None of the graphics, descriptions, research, excerpts, samples or any other content provided in the report(s) or any of its research publications may be reprinted, reproduced, redistributed or used for any external commercial purpose without prior permission from Avasant, LLC. All rights are reserved by Avasant, LLC.

Welcome to Avasant

LOGIN

Login to get free content each month and build your personal library at Avasant.com

NEW TO AVASANT?

Welcome to Avasant